The MedCan Summit remains the key educational conference for this new industry in New Zealand, and as such, BioTechNZ is committed to running it this year.
New Zealand is strongly placed to be the premier new-world medicinal cannabis producer by leveraging our favourable growing conditions, unique strains, breeding programmes, expertise in data management and our leading clinical trials capability. The Summit aims to engage, educate and inspire this new industry, while also ensuring that medical professionals have the knowledge to prescribe medicinal cannabis products.
We would like to thank all of our sponsors, speakers and delegates for their patience as we worked out the details of the postponed event.
Everything you need to know at this stage about the November MedCan Summit is detailed below, however, if you have any other questions, please email us: firstname.lastname@example.org
We look forward to seeing you in November!
We will endeavour to keep the programme as similar as possible to the original MedCan Summit programme, plus we may add new content now that the Medicinal Cannabis Scheme has taken effect.
Due to travel restrictions it may not be possible for all of our international speakers to attend in-person, so arrangements will be made for them to present virtually, if required.
As per the original programme, the first day of MedCan Summit 2020 will be a pre-summit workshop. This interactive day is aimed at both health professionals and industry players. Health professionals will learn more about clinical data and opportunities for the New Zealand clinical trials sector, while the industry stream will take a deep dive into the cultivation, manufacturing and commercialisation of medicinal cannabis.
This will take place on Monday 9 November.
The CME credits available for medical professionals will still apply.
If you can no longer attend:
If you are unable to attend MedCan Summit 2020 in person, you will be able to access a live stream to ensure you can still participate in the Summit. We will contact you closer to the Summit to confirm whether you will be attending in person or online.
For anyone who is unable to attend physically or virtually, you will be able to receive a full refund if you cancel your registration by 29 May. If you would like to cancel your registration, please email us.
If you cancel after 29 May, a 25% non-refundable cancellation policy will apply.
Health and safety:
The health and safety of our speakers, attendees, sponsors and events team is our biggest priority. As such, we will work with the venue to ensure that we adhere to all Ministry of Health guidelines for holding large events. Find out more here.
We will continue to monitor the COVID-19 situation in New Zealand and keep you informed as soon as possible if there are any changes.
The planned exhibition will still go ahead, with measures in place to ensure that appropriate physical distancing can be observed.
There will be a limited number of tickets available for purchase for people who have not yet registered for MedCan Summit 2020. Tickets can be purchased here.
We know that November may seem far away, so the MedCan Summit webinar series for delegates will continue until then, with monthly webinars to keep you informed about developments in the industry.
Join us for our third webinar at 3pm on Wednesday 20 May which will explore how telemedicine is helping patients to access expert medicinal cannabis advice during the COVID-19 lockdown period, and how it is shaping the new ways of working.
MedCan Summit delegates have received an email with the link to register.
We are grateful to each of our sponsors who are committed to the industry and the Summit and are supporting us to deliver the MedCan Summit 2020 in November.
Paul Manning, CEO of Helius Therapeutics which is the summit’s foundation sponsor, says Helius’ support for the event has never wavered and he’s delighted the new dates and venue have now been confirmed.
“This is a watershed year for medicinal cannabis. Now that we have a regulatory scheme in place, MedCan Summit is bringing together all the industry’s key stakeholders for the first time. The event will help build relationships, support healthcare professionals, and improve public health outcomes. Ensuring New Zealand’s medicinal cannabis industry thrives is now more important than ever before,” says Mr Manning.
“We’re thrilled to help fund this event, for the advancement of the country’s medicinal cannabis industry.”
MedCan Summit gold sponsor SETEK Therapeutic is also excited with the announcement.
“We are thrilled to see the MedCan Summit rescheduled for November 2020 and look forward to an innovative conference in the evolving medical cannabis market,” says David Pearce, Co-Chief Executive of SETEK Therapeutics.
AJ Park, a MedCan Summit silver sponsor, shares the sentiment.
“We’re thrilled that the new date for MedCan has been confirmed and we’re looking forward to being part of the 2020 summit. AJ Park is committed to helping the medicinal cannabis sector develop, protect and commercialise their brands, products, ideas and innovations,” says AJ Park’s Chief Operating Officer Andrea Dickens.
Spectrum Therapeutics, a MedCan Summit silver sponsor, is pleased the summit has been confirmed in November.
“Spectrum Therapeutics is pleased with the relaunch of MedCan Summit in November 2020. We remain committed to the supply of pharmaceutical-grade medicinal cannabis products for patients in New Zealand. While the Medicinal Cannabis Scheme was launched in April, there remains an opportunity to improve the education of doctors so they can make informed prescribing decisions for their patients. MedCan Summit will provide the opportunity to share the current scientific evidence with healthcare practitioners, researchers, regulators and industry stakeholders.” says Senior Medical Science Liaison Kady Chemal.
MedCan Summit Networking Sponsor Cannasouth is pleased the event will be going ahead in November.
“We look forward to coming together with industry stakeholders in November to run through the impressive agenda put together for the MedCan Summit,” says Mark Lucas, Chief Executive Officer of Cannasaouth.